There are four emerging powerhouses in China biotech: Henlius, BeiGene, Innovent and ZaiLab. All were founded in the 2010s, ...

BERLIN (Reuters) -Swiss biotech investor Xlife Sciences AG said on Wednesday its portfolio company Veraxa Biotech AG would list on U.S. exchange Nasdaq in a $1.64 billion merger deal with a ...

Biotech was starting to show signs of recovery after years of investor pullback—until new tariffs and economic uncertainty ...

Switzerland's Xlife Sciences AG said on Wednesday its portfolio company, VERAXA Biotech AG, will merge with Voyager Acquisition in a deal that will value the combined company at $1.64 billion. The ...

Paul Stoffels left his perch as J&J’s chief scientific officer in 2022 to replace Galapagos’ founding CEO Onno van de Stolpe, ...

GenScript Biotech Corporation, a global leader in biotechnology research services, and NSG Bio, Singapore's premier biotech ...

A central Ohio biotechnology company that operated facilities in West Jefferson and New Albany has shut down, resulting in ...

The biotech mergers and acquisitions market faces significant headwinds in the first half of 2025. These challenges include frozen capital ...

Swiss pharmaceuticals powerhouse Roche says it plans to invest $50 billion in the United States over the next five years and ...

LUND, SE / ACCESS Newswire / April 23, 2025 / Alligator Bioscience (Nasdaq Stockholm:ATORX) today announces that Shanghai Henlius Biotech, Inc. ("Henlius") has initiated a Phase 2 clinical trial with ...